Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211288 · ClinicalTrials.gov registry record · NA
Longitudinal Study of Dental Implant Therapy in HIV Positive Patients
A NA study of Dental Implant, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT01211288: Completed NA study of Dental Implant, sponsored by University of Alabama at Birmingham.
NCT01211288 is a NA study of Dental Implant that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 41 participants, above the 30-participant average among 8 other Dental Implant trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211288, a NA study of Dental Implant, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose is to place implants in HIV positive and HIV negative patients then follow patients over 3 years period of time to evaluate how well dental implants perform in HIV positive patients versus HIV negative patients.
Primary Outcome
Dental implant supported restorations functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.
Conditions Studied
Interventions
- DEVICE Astra implants
Study Locations (1)
Alabama
- UAB Dental School - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-05 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
What the finished NCT01211288 record still lists
NCT01211288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, above the 30-participant average among 8 other Dental Implant trials with a reported enrollment target (37% higher).
The record links to 1 condition, with Dental Implant appearing as the primary indexed condition, and to 1 intervention - of which Astra implants is the first listed.
NCT01211288 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT01211288 about?
NCT01211288 is a clinical study titled "Longitudinal Study of Dental Implant Therapy in HIV Positive Patients". The purpose is to place implants in HIV positive and HIV negative patients then follow patients over 3 years period of time to evaluate how well dental implants perform in HIV positive patients versus HIV negative patients.
What is the current status of trial NCT01211288?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2010-05. Estimated completion is 2020-05-01.
What conditions does trial NCT01211288 study?
This clinical trial studies the following conditions: Dental Implant.
What interventions are being tested in trial NCT01211288?
The interventions under investigation include: Astra implants (DEVICE).
Who is sponsoring clinical trial NCT01211288?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01211288 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Implant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01211288's enrollment target sits among peer trials
41 3rd of 8 higher than 5 of 8 other Dental Implant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dental Implant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor
RECRUITING · NA
-
Closed Sinus Augmentation With a Calcium Phosphosilicate Putty
RECRUITING · NA
-
Evaluation of Sinus Augmentation Bone Healing Using Autograft and Xenograft Compared to Xenograft Alone
ACTIVE NOT RECRUITING · NA
-
A Randomized Prospective Clinical Trial Comparing Single Tooth Implant 3 Loading Protocols
COMPLETED · NA
-
Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
COMPLETED · NA
-
To Compare Different Soft Tissue Grafts at the Time of Lateral Ridge Augmentation Procedure.
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia